Skip to main content
. 2023 Mar;57(1):22–31. doi: 10.15644/asc57/1/3

Table 2. Medical conditions.

Medical condition N (total) % (total) Children/adults % of children p *
Retardatio mentalis 358 44.2 127/231 35.5 <0.001
Epilepsy 267 33.0 111/156 41.6 0.001
Autism 155 19.1 107/48 69.0 <0.001
Tetraparesis sp 139 17.2 50/89 36.0 <0.001
Cerebral paralysis 130 16.0 66/64 50.8
Retardatio psihomotorica 64 7.9 31/33 48.4
Delayed psychomotor development 47 5.6 32/15 68.1 0.016
Gastrointestinal diseases 47 5.8 19/28 40.4
Cardiomyopathies 39 4.8 23/16 58.9
Down syndrome 37 4.7 16/21 43.2
Attention disturbances 37 4.6 28/9 75.7 0.002
Undeveloped speech 36 4.4 28/8 77.8 0.001
Dental phobia 34 4.2 30/4 88.2 <0.001
Obesity 31 3.8 6/25 19.4 <0.001
Blood disorders 25 3.1 6/19 24.0 0.008
Hormonal distrubances 25 3.1 11/14 44.0
Psychiatric disturbances 24 3.0 6/18 25.0 0.013
Other chromosomopathies 23 2.8 18/5 78.3 0.010
Sy West 21 2.6 10/11 47.6
Asthma 21 2.6 14/7 66.7
Chronic respiratory diseases 15 1.9 10/5 66.7
Vision disturbances 12 1.5 8/4 66.7
Sy Dardy Walker 12 1.5 7/5 58.3
Malignant diseases 10 1.2 5/5 50.0
Cleft lip/palate 5 0.6 3/2 60.0
Sy di George 5 0.6 4/1 80.0
Sy Struge Weber 2 0.2 1/1 50.0
Glaucoma 2 0.2 1/1 50.0
Children - subjects aged <18; N –frequency; % - percentage; p – significance level; * bold – significant difference between children and adults